Johnson & Johnson News - October 13, 2026
J&J Beats Estimates But Shares Sink 4.3%: Can a Slimmer Company Outrun Geopolitical Drag and Earnings-Quality Questions?
Shares dropped sharply as Johnson & Johnson's Q3 report delivered a paradox: headline numbers that technically cleared the bar, but underlying details that...
🔴 Johnson & Johnson is trading 4.3% down today as Middle East conflict weighed on device sales
Johnson & Johnson is trading 4.3% down at $252.52 after its October 13 third-quarter report disappointed investors, with Middle East conflict weighing on...
Johnson & Johnson’s third quarter 2026 sales matched estimates at $25.4B while Innovative Medicine outperformed
Johnson & Johnson reported third quarter 2026 results featuring solid operational sales growth of 6.0%, driven by outperformance in its Innovative Medicine...
🔴 Johnson & Johnson is trading 3.13% down in pre-market following Q3 results
Johnson & Johnson is trading at $255.48, down 3.13% in pre-market following its Q3 earnings announcement. - Before the October 13 open, adjusted EPS was...